Biotechnology Bulletin ›› 2022, Vol. 38 ›› Issue (10): 159-163.doi: 10.13560/j.cnki.biotech.bull.1985.2022-0042

Previous Articles     Next Articles

Production of Marker-free Mutants of Brassica campestris Mediated by CRISPR/Cas9 Through Vacuum Infiltration

ZONG Mei(), HAN Shuo, GUO Ning, DUAN Meng-meng, LIU Fan, WANG Gui-xiang()   

  1. Vegetable Research Institute of Beijing Academy of Agriculture and Forestry Sciences/Key Laboratory of Biology and Genetic Improvement of Horticultural Crops(North China),Ministry of Agriculture and Rural Affairs,P. R. China/Beijing Key Laboratory of Vegetable Germplasm Improvement,Beijing 100097
  • Received:2022-01-10 Online:2022-10-26 Published:2022-11-11
  • Contact: WANG Gui-xiang E-mail:zongmei@nercv.org;wangguixiang@nercv.org

Abstract:

The objective is to acquire non-transgenic Brassica campestris mutants via CRISPR/Cas9 gene editing system,for achieving the application of CRISPR/Cas9 in B. campestris in planta transformation method and providing reference for application of marker-free gene editing technique. Using ‘49 Caixin’ as plant material and dehydrogenase gene(PDS)as target gene,total of 25 plants were transformed by in planta transformation via vacuum-infiltration method. The results showed that 3 of the 2 032 transformed seedlings were identified to have PDS gene editing,one of which was detected to have exogenous vector insertion and heterozygous editing of PDS gene,and the phenotype was consistent with that of the wild type. The other two seedlings had a dwarf,albino phenotype,and there was no insertion of foreign vector in their genomes. Different types of targeted mutagenesis of PDS gene were detected in these two seedlings compared with the wild type. In conclusion,gene editing can be achieved in B. campestris by CRISPR/Cas9 through in planta tissue culture-independent transformation,and particularly non-transgenic editing mutants without exogenous insertion can be obtained directly.

Key words: Brassica campestris, marker-free, vacuum infiltration transformation, tissue culture-independent, CRISPR/Cas9